Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder.
Clinical trial NCT02163915 · TERMINATED
Trial details
- NCT number
- NCT02163915
- Sponsor
- Takeda
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2014-11-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.